Urania Therapeutics

Urania Therapeutics leverages the expertise of Marat Yusupov and Gulnara Yusupova in the field of ribosome crystallography to develop new drugs. Urania is developing readthrough compounds targeting the human ribosome, using a structure-based drug design approach for the treatment of genetic disorders and certain cancers caused by mutations.